These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6598803)

  • 1. Inhibition of plasma membrane NADH dehydrogenase by adriamycin and related anthracycline antibiotics.
    Sun IL; Crane FL; Löw H; Grebing C
    J Bioenerg Biomembr; 1984 Jun; 16(3):209-21. PubMed ID: 6598803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diferric transferrin reductase in the plasma membrane is inhibited by adriamycin.
    Sun IL; Navas P; Crane FL; Morré DJ; Löw H
    Biochem Int; 1987 Jan; 14(1):119-27. PubMed ID: 3566771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin?
    Morré DJ; Kim C; Paulik M; Morré DM; Faulk WP
    J Bioenerg Biomembr; 1997 Jun; 29(3):269-80. PubMed ID: 9298712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformed liver cells have modified transplasma membrane redox activity which is sensitive to adriamycin.
    Sun IL; Crane FL; Chou JY; Löw H; Grebing C
    Biochem Biophys Res Commun; 1983 Oct; 116(1):210-6. PubMed ID: 6639658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the mechanism of inhibition of NADH oxidase by ubiquinone-3.
    Landi L; Pasquali P; Cabrini L; Sechi AM; Lenaz G
    J Bioenerg Biomembr; 1984 Apr; 16(2):153-66. PubMed ID: 6536673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates.
    Sun IL; Sun EE; Crane FL; Morré DJ; Faulk WP
    Biochim Biophys Acta; 1992 Mar; 1105(1):84-8. PubMed ID: 1567898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin effects on transplasma membrane redox functions in porcine neutrophils.
    McLoughlin PM; Sun IL; Crane FL
    Biochim Biophys Acta; 1984 Nov; 802(1):71-6. PubMed ID: 6091773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity.
    Iwamoto Y; Hansen IL; Porter TH; Folkers K
    Biochem Biophys Res Commun; 1974 Jun; 58(3):633-8. PubMed ID: 4152017
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV.
    Nicolay K; de Kruijff B
    Biochim Biophys Acta; 1987 Jul; 892(3):320-30. PubMed ID: 3036220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase.
    Doroshow JH
    Cancer Res; 1983 Oct; 43(10):4543-51. PubMed ID: 6309369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of a doxorubicin-inhibited NADH-quinone (NADH-ferricyanide) reductase from rat liver plasma membranes.
    Kim C; Crane FL; Faulk WP; Morré DJ
    J Biol Chem; 2002 May; 277(19):16441-7. PubMed ID: 11875069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition and inactivation of NADH-cytochrome c reductase activity of bovine heart submitochondrial particles by the iron(III)-adriamycin complex.
    Hasinoff BB
    Biochem J; 1990 Feb; 265(3):865-70. PubMed ID: 2306220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplasmalemma NADH dehydrogenase is inhibited by actinomycin D.
    Sun IL; Crane FL
    Biochem Biophys Res Commun; 1981 Jul; 101(1):68-75. PubMed ID: 7284008
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of oxygen by NADH/NADH dehydrogenase in the presence of adriamycin.
    Thornalley PJ; Bannister WH; Bannister JV
    Free Radic Res Commun; 1986; 2(3):163-71. PubMed ID: 2850270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclines.
    Kharasch ED; Novak RF
    Arch Biochem Biophys; 1983 Jul; 224(2):682-94. PubMed ID: 6408991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin-adriamycin conjugates which inhibit tumor cell proliferation without interaction with DNA inhibit plasma membrane oxidoreductase and proton release in K562 cells.
    Faulk WP; Barabas K; Sun IL; Crane FL
    Biochem Int; 1991 Dec; 25(5):815-22. PubMed ID: 1666508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of erythrocyte plasma membrane NADH dehydrogenase by nucleotides and uncouplers.
    Howland JL; Osrin D; Donatelli M; Theofrastous JP
    Biochim Biophys Acta; 1984 Dec; 778(3):400-4. PubMed ID: 6509043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin inhibits NADH-semidehydroascorbate reductase in rat liver plasma membrane.
    Goldenberg H
    Biochem Biophys Res Commun; 1980 May; 94(2):721-6. PubMed ID: 6994727
    [No Abstract]   [Full Text] [Related]  

  • 19. Transformation with SV40 virus prevents retinoic acid inhibition of plasma membrane NADH diferric transferrin reductase in rat liver cells.
    Sun IL; Toole-Simms W; Crane FL; Morré DJ; Löw H; Chou JY
    J Bioenerg Biomembr; 1988 Jun; 20(3):383-91. PubMed ID: 2841310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthracenedione activation by NADPH-cytochrome P-450 reductase; comparison with anthracyclines.
    Kharasch ED; Novak RF
    Biochem Pharmacol; 1981 Oct; 30(20):2881-4. PubMed ID: 6274352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.